van der Wilt C L, Pinedo H M, Smid K, Cloos J, Noordhuis P, Peters G J
Free University Hospital, Department of Oncology, Amsterdam, The Netherlands.
Semin Oncol. 1992 Apr;19(2 Suppl 3):16-25.
Folinic acid (leucovorin, [LV]) can potentiate the growth inhibitory effects of fluorouracil (5-FU) in vitro and in vivo. LV is a precursor for 5,10-methylene-tetrahydrofolate (CH2-THF). Sufficient levels of CH2-THF enhance the inhibition of the enzyme thymidylate synthase by the 5-FU metabolite FdUMP. This study describes the effects of 5-FU and LV in two murine (C26-10, C38-1) and two human (WiDr, HT-29) colon carcinoma cell lines and in two murine tumors (Colon 26 and Colon 38). In vitro, only C38-1 was more sensitive for the combination of LV/5-FU compared with 5-FU alone. This effect was not dose or schedule dependent. l-LV, a purified stereo-isomere of LV, is thought to be the biological active form. Tests with this compound in vitro did not show a better effect than the mixture of d- and l-LV. In vivo, dl-LV could potentiate 5-FU antitumor effect in two murine colon tumors (Colon 26, Colon 38). This effect was clearly schedule dependent. dl-LV administered 1 hour before and together with 5-FU was much better than only simultaneous or posttreatment, but there was no dose dependency, while like in vitro l-LV effect was comparable to dl-LV. TdR was used to study the role of TS inhibition in the growth inhibitory effect of 5-FU with and without LV. TdR can reverse growth inhibition caused by TS inhibition due to 5-FU. In vitro, a partial reversal of growth inhibition of 5-FU and 5-FU/LV was observed, but in vivo there was no reversal. In vivo, TdR combinations led to high toxicity. Measurements of TS amounts in cells and tumors showed that those of human origin had much lower TS than the murine. C38-1 and Colon 38 with low TS were more sensitive to 5-FU than Colon 26 with higher TS amounts. TS inhibition was studied in the two murine colon tumors at several time points after weekly 5-FU or LV and 5-FU administration. LV did not increase the extent or retention of TS inhibition due to 5-FU during the first week. After three courses of treatment a fourfold increase of TS levels was seen in Colon 26 after 5-FU therapy. This resulted in a less effective TS inhibition after this treatment. Tumors treated with 5-FU and LV also showed an increase of TS, but to a lower extent, while the effect on TS inhibition remained the same.(ABSTRACT TRUNCATED AT 400 WORDS)
亚叶酸(甲酰四氢叶酸,[LV])在体外和体内均可增强氟尿嘧啶(5-FU)的生长抑制作用。LV是5,10-亚甲基四氢叶酸(CH2-THF)的前体。足够水平的CH2-THF可增强5-FU代谢产物FdUMP对胸苷酸合成酶的抑制作用。本研究描述了5-FU和LV对两种小鼠(C26-10、C38-1)和两种人(WiDr、HT-29)结肠癌细胞系以及两种小鼠肿瘤(结肠26和结肠38)的影响。在体外,与单独使用5-FU相比,只有C38-1对LV/5-FU联合用药更敏感。这种效应与剂量或给药方案无关。l-LV是LV的一种纯化立体异构体,被认为是生物活性形式。该化合物的体外试验未显示出比d-和l-LV混合物更好的效果。在体内,dl-LV可增强5-FU对两种小鼠结肠肿瘤(结肠26、结肠38)的抗肿瘤作用。这种效应明显依赖于给药方案。在5-FU前1小时及同时给予dl-LV比仅同时给药或在5-FU后给药效果要好得多,但不存在剂量依赖性,且与体外情况一样,l-LV的效果与dl-LV相当。用胸苷(TdR)研究了TS抑制在有或无LV时5-FU生长抑制作用中的作用。TdR可逆转由5-FU引起的TS抑制所导致的生长抑制。在体外,观察到5-FU和5-FU/LV的生长抑制有部分逆转,但在体内则没有逆转。在体内,TdR联合用药导致高毒性。对细胞和肿瘤中TS含量的测量表明,人源的TS含量远低于小鼠。TS含量低的C38-1和结肠38比TS含量高的结肠26对5-FU更敏感。在每周给予5-FU或LV及5-FU后的几个时间点,对两种小鼠结肠肿瘤中的TS抑制进行了研究。在第一周,LV并未增加由5-FU引起的TS抑制的程度或持续时间。在三个疗程的治疗后,结肠26在接受5-FU治疗后TS水平增加了四倍。这导致该治疗后TS抑制效果降低。用5-FU和LV治疗的肿瘤也显示TS增加,但程度较低,而对TS抑制的影响保持不变。(摘要截选至400字)